SCHEMBL2893707

SCHEMBL2893707

CC(C)n1c(=O)c(OC(=O)C(F)(F)F)c2n(c1=O)C(CCN(C)Cc1ccccc1)CN(Cc1ccc(F)cc1)C2=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
TSHR P16473 2/20 0.35
ALDH1A1 P00352 1/20 0.35
CYP2D6 P10635 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HMGCR P04035 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.33
HTT P42858 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
ACKR3 P25106 1/20 0.32
TMEM97 Q5BJF2 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
GAA P10253 2/20 0.31
ACHE P22303 1/20 0.31
KDM4E B2RXH2 1/20 0.31
LMNA P02545 1/20 0.31
RORC P51449 1/20 0.31
GNRHR P30968 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2900174 0.92 KMT2A (0.38) KMT2AMEN1TSHRALDH1A1CYP2D6
SCHEMBL4230594 0.89 KMT2A (0.37) KMT2AMEN1TSHRALDH1A1CYP2D6
Trifluoroacetic Acid SCHEMBL2891881 0.88 KMT2A (0.40) KMT2AMEN1TSHRALDH1A1CYP2D6
SCHEMBL2898698 0.86 KMT2A (0.39) KMT2AMEN1TSHRALDH1A1CYP2D6
SCHEMBL2899620 0.81 HMGCR (0.35) HMGCRL3MBTL1HTTLMNA
SCHEMBL2890889 0.80 ACHE (0.32) KMT2AMEN1TSHRALDH1A1CYP2D6
SCHEMBL2894653 0.80 MEN1 (0.33) KMT2AMEN1ALDH1A1CYP2D6HMGCR
SCHEMBL2900634 0.76 ACHE (0.40) KMT2ACYP2D6HMGCRHTTACHE
SCHEMBL2900482 0.75 TP53 (0.34) KMT2AMEN1TSHRALDH1A1CYP2D6
SCHEMBL13085834 0.75 TP53 (0.35) ALDH1A1HMGCRHTTGAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7820680-B2 HIV integrase inhibitors MERCK & CO., INC. (US) 2010-10-26 US disclosed
US-20080009490-A1 Hiv Integrase Inhibitors MERCK SHARP & DOHME CORP. 2008-01-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080009490-A1 Hiv Integrase Inhibitors TYMS, UNG, TYMP KMT2A 1314/4885MEN1 4641/4885TSHR 4386/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.